McKesson Europe AG operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares McKesson Europe AG with three other
drug stores in Europe:
Selcuk Ecza Deposu Ticaret ve Sanayi AS
sales of 10.69 billion Turkish Liras [US$2.63 billion]
of which 100%
was Medical and Hospital Equipment),
(3.21 billion Swiss Francs [US$3.32 billion]
of which 78%
was Services), and
based in Poland
(7.49 billion Polish New Zlotys [US$2.20 billion]
of which 99%
was Pharmaceutical Wholesale).
McKesson Europe AG reported sales of 20.64 billion Euro (US$25.33 billion)
March of 2017.
decrease of 3.6%
versus 2016, when the company's sales were 21.41 billion Euro.
The sales level in 2017 was fairly close to the level five years ago: in 2012, McKesson Europe AG had sales
of 22.27 billion Euro.
Contributing to the drop in overall sales was the 7.3% decline
in Patient and Consumer Solutions, from 4.14 billion Euro to 3.84 billion Euro.
There were also decreases in sales in
Pharmacy Solutions (down 2.7% to 16.81 billion Euro)